One in three overdue for cervical cancer screening across UK
A third of people across the UK are overdue their cervical cancer screening, while in parts of England some are at greater risk of the disease than others due to a low uptake for the preventive vaccine, experts have warned.
Since the coronavirus pandemic, cervical screening attendance rates have been steadily declining, from 72.2% in 2020 to 68.4% in 2024, NHS England data shows.
A YouGov survey of 3,000 people across the UK eligible for cervical cancer screening, commissioned by Cancer Research UK, is in line with these findings, with 30% of respondents being overdue their screening.
It also highlighted the main barriers people cited, with 42% of respondents finding cervical screening painful previously, 40% not wanting a man to carry out the screening test, and just under one in five (19%) of respondents saying they were too embarrassed to go for a screening.
Of those who did not attend their screening, 16% of respondents said it was because they didn't have any symptoms, highlighting the misinformation still prevalent regarding cervical screening, which is for people without symptoms.
Separate figures from the UK Heath Security Agency (UKHSA) have found that uptake of the HPV vaccine greatly varies by region, with girls in London by year 10 having the lowest uptake (64.9%) and girls in the south-east the highest (82.7%). Among boys of the same age, it was also lowest in London (58.9%) and highest in the south-east (77.3%).
HPV refers to a group of viruses that can be transmitted through sexual contact and cause no symptoms. About 13 high-risk types of HPV are known to cause 99.7% of cervical cancers.
Each year, about 3,200 women in the UK are diagnosed with cervical cancer and 850 die from it. It is the 14th most common cancer affecting women in Britain, with women aged 30 to 34 most likely to receive a diagnosis. Last year, NHS England pledged to wipe out cervical cancer by 2040.
Globally, it is the fourth most common cancer in women, with about 660,000 new cases and 350,000 deaths every year, according to the World Health Organization.
The disease develops when abnormal cells appear in the lining of the cervix and grow, eventually coming together as a tumour. If the cells are not caught early, the cancer can spread to other parts of the body.
In June, NHS England said that women aged between 25 and 49 who test negative for HPV, meaning they are at very low risk of cervical cancer over the next 10 years, will safely be invited at five-year intervals instead of three.
Fiona Osgun, Cancer Research UK's head of health information, said the declining rates were due to a combination of factors.
Sign up to First Edition
Our morning email breaks down the key stories of the day, telling you what's happening and why it matters
after newsletter promotion
'We know that people have specific barriers to accessing screening; some of those are practical such as not being able to get an appointment at a time that works for them, but some are more specific to the test itself, such as finding the screening painful or being worried about who's going to be carrying out the test,' Osgun said.
'I think we have just seen a slow decline, which unfortunately can happen even with successful screening programmes. We need to continue to chip away at those misunderstandings and misconceptions some people have regarding cervical screening.'
Osgun added that there were various measures people could ask for to make their cervical screening test more comfortable, such as asking for a double appointment or a different-sized speculum.
Dr Amanda Doyle, national director for primary care and community services at NHS England, said: 'The NHS HPV vaccination programme has already helped save thousands of lives and we need to go further to boost uptake of HPV vaccines and cervical screening to help eliminate cervical cancer in England by 2040.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Rhyl Journal
3 hours ago
- Rhyl Journal
ADHD waiting list led to rise in unregulated private providers
The ADHD taskforce, commissioned by NHS England with the support of the Government, has published an interim report saying the system for diagnosing and managing ADHD needs to be overhauled. At the moment, ADHD assessment and treatment in England is provided by highly specialised doctors in secondary care. But the report warned: 'Inability to access NHS services has led to a significant growth in the use of private providers that are not regulated, resulting in two-tier access to services, diagnosis and treatment; one for those who can pay and another for those who cannot. 'This drives health inequalities and links to disproportionate impacts and outcomes in the education and justice systems, employment and health.' Experts behind the study said waiting times for NHS ADHD services 'have escalated and are unacceptably long' and demand on services is 'very likely' to continue to rise. The taskforce concluded that ADHD is not solely the remit of the NHS and other health providers, with schools being vital for identifying and meeting needs at an early stage. And while a clinical diagnosis of ADHD via the NHS is required if a person needs medication, early support can still be provided to others. The report said: 'We need timely recognition and early support of suspected ADHD and neurodivergence across all settings. 'This is especially important in schools and the early years, to prevent adverse impacts and costly outcomes in the future. This should be needs-led and not require a clinical diagnosis.' The report also suggested there is no evidence of over-diagnosis of ADHD in the UK. It argued: 'England and the rest of the UK have much lower service recognition and treatment rates of ADHD diagnosis compared with other European countries. 'Recent data show a very high level of under-recognition and under-treatment of strictly diagnosed ADHD, with significant inequalities in access to care.' The report also addressed concerns about potential 'over-medicalisation and over-diagnosis', including worries that people are self-diagnosing ADHD based on information from social media. However, the report, said that 'currently there is no good evidence on what percentage of those waiting to see a clinician have self-diagnosed ADHD using social media and eventually meet or do not meet ADHD diagnostic criteria after a high-quality assessment. 'We only know currently that in England, recognised rates of ADHD are lower than the expected prevalence of ADHD.' Currently, the estimated economic costs of not treating ADHD are around £17 billion to the UK economy, the report went on. This includes through lower tax contributions, people needing state benefits and more likely to be not in education, employment or training, or who are long-term unemployed. 'Many of these costs are avoidable, as with appropriate, early support, people with ADHD can thrive,' it said. Professor Anita Thapar, chair of the ADHD Taskforce, said: 'The recommendations put forward by the taskforce will require action across Government and cross-sector organisations to make the necessary changes to improve the lives of people with ADHD. 'We need to get this right, to make sure people get early diagnosis and support, not just in the NHS but across society.' Dr Adrian James, NHS England's medical director for mental health and neurodiversity, said: 'We know that too many people with ADHD have been waiting for too long for support, which is why we launched the taskforce last year to help respond to the significant growth in the need for care. 'It is clear that much more needs to be done to improve ADHD assessment and care in England and ensure people can get a timely diagnosis, and we welcome the findings from the interim report, and look forward to its final conclusions later this year.' A Department of Health and Social Care spokesperson said: 'Lord Darzi's report into the state of the NHS laid out how severe the delays have become for people waiting for an attention deficit hyperactivity disorder diagnosis. 'We welcome the publication of the ADHD Taskforce's interim report, which provides valuable insights into the challenges affecting those with ADHD, including access to services and support.' The NHS has launched publicly-available data collection on ADHD referrals and waiting times to help local teams better understand how they are performing. By March 2026, the Government also aims for six in 10 pupils to have access to a mental health support team in school.
The Guardian
6 hours ago
- The Guardian
One in three overdue for cervical cancer screening across UK
A third of people across the UK are overdue their cervical cancer screening, while in parts of England some are at greater risk of the disease than others due to a low uptake for the preventive vaccine, experts have warned. Since the coronavirus pandemic, cervical screening attendance rates have been steadily declining, from 72.2% in 2020 to 68.4% in 2024, NHS England data shows. A YouGov survey of 3,000 people across the UK eligible for cervical cancer screening, commissioned by Cancer Research UK, is in line with these findings, with 30% of respondents being overdue their screening. It also highlighted the main barriers people cited, with 42% of respondents finding cervical screening painful previously, 40% not wanting a man to carry out the screening test, and just under one in five (19%) of respondents saying they were too embarrassed to go for a screening. Of those who did not attend their screening, 16% of respondents said it was because they didn't have any symptoms, highlighting the misinformation still prevalent regarding cervical screening, which is for people without symptoms. Separate figures from the UK Heath Security Agency (UKHSA) have found that uptake of the HPV vaccine greatly varies by region, with girls in London by year 10 having the lowest uptake (64.9%) and girls in the south-east the highest (82.7%). Among boys of the same age, it was also lowest in London (58.9%) and highest in the south-east (77.3%). HPV refers to a group of viruses that can be transmitted through sexual contact and cause no symptoms. About 13 high-risk types of HPV are known to cause 99.7% of cervical cancers. Each year, about 3,200 women in the UK are diagnosed with cervical cancer and 850 die from it. It is the 14th most common cancer affecting women in Britain, with women aged 30 to 34 most likely to receive a diagnosis. Last year, NHS England pledged to wipe out cervical cancer by 2040. Globally, it is the fourth most common cancer in women, with about 660,000 new cases and 350,000 deaths every year, according to the World Health Organization. The disease develops when abnormal cells appear in the lining of the cervix and grow, eventually coming together as a tumour. If the cells are not caught early, the cancer can spread to other parts of the body. In June, NHS England said that women aged between 25 and 49 who test negative for HPV, meaning they are at very low risk of cervical cancer over the next 10 years, will safely be invited at five-year intervals instead of three. Fiona Osgun, Cancer Research UK's head of health information, said the declining rates were due to a combination of factors. Sign up to First Edition Our morning email breaks down the key stories of the day, telling you what's happening and why it matters after newsletter promotion 'We know that people have specific barriers to accessing screening; some of those are practical such as not being able to get an appointment at a time that works for them, but some are more specific to the test itself, such as finding the screening painful or being worried about who's going to be carrying out the test,' Osgun said. 'I think we have just seen a slow decline, which unfortunately can happen even with successful screening programmes. We need to continue to chip away at those misunderstandings and misconceptions some people have regarding cervical screening.' Osgun added that there were various measures people could ask for to make their cervical screening test more comfortable, such as asking for a double appointment or a different-sized speculum. Dr Amanda Doyle, national director for primary care and community services at NHS England, said: 'The NHS HPV vaccination programme has already helped save thousands of lives and we need to go further to boost uptake of HPV vaccines and cervical screening to help eliminate cervical cancer in England by 2040.'
Daily Mail
6 hours ago
- Daily Mail
Revealed: Areas of UK where young people could be at greater risk of cancer linked to oral sex - do YOU live in one of them?
Almost three quarters of teens in some parts of England are missing out on a crucial anti-cancer vaccine, health officials warned today. The jab is offered to children aged 12 to 13 to protect them against human papillomavirus. Infection with the virus—also known as HPV —can trigger several types of cancers, including those in the head, neck and cervix. HPV is commonly spread through vaginal, anal and oral sex with someone who is already infected, with around a third of people infected at any one time. While a highly HPV effective vaccine has been offered to all girls in Year 8 since 2008, and all boys since 2019, latest data shows as few as a third of children in some areas of England are not getting it—leaving them vulnerable in later life. Experts have now urged parents to ensure their child gets the vaccine, labelling it 'one of the most powerful tools we have for cancer prevention'. It comes amid a documented rise in head and neck cancers, particularly among younger and middle-aged patients, which has been linked to HPV spreading via oral sex. Research has suggested that HPV may be responsible for up to 70 per cent of head and neck cancers. The virus is also responsible for almost all (99.7 per cent) of all cases of cervical cancer, a form of the disease that develops in a women's cervix. Nationally, more than one in four young people eligible for the jab haven't taken up the jab, according to data for the 2023 to 2024 academic year. But, analysis shows that uptake is far lower in certain parts of the nation. The borough of Brent in north-west London recorded the lowest HPV uptake of any local area, with only one in four girls in Year 9—aged 13 or 14—having had the jab. It was the affluent borough of Kensington and Chelsea, however, which recorded the lowest uptake for boys in Year 9—with just 25.8 per cent taking up the vaccine. Meanwhile, among Year 10 students—aged 14 or 15—vaccination levels in girls ranged from 38.7 per cent (Lambeth in London) to 97.6 per cent (Northumberland). Among boys, it ranged from 28.2 per cent (Lambeth in London) to 92.2 per cent (West Berkshire). Dr Sharif Ismail, consultant epidemiologist at UK Health Security Agency (UKHSA), said: 'The HPV vaccine, now just a single dose offered in schools, is one of the most powerful tools we have for cancer prevention. 'Every vaccination represents a young person with better protection against the devastating impact of HPV-related cancers, and we must do more to ensure that no teenage girl or boy, young woman or man is denied that protection no matter where they live. 'We're calling on all parents to return their children's HPV vaccination consent forms promptly. 'This simple action could protect your child from developing cancer in the future.' Dr Ismail said any young adult up to age 25 who missed their school jab can also speak to their GP about catch-up options. He also urged women to still attend cervical screening to ensure they are being checked for changes that could lead to cervical cancer. Cancer Research UK chief executive Michelle Mitchell added: 'Thanks to the power of research and the efforts of NHS staff, a future where almost nobody gets cervical cancer is in sight. 'This progress hinges on people's access to two life-saving offers—HPV vaccination and screening. Together, they give the best protection against the disease. 'Beating cervical cancer means beating it for everyone, so I encourage all parents and guardians to ensure young people don't miss out on getting the HPV vaccine. 'And if you receive your cervical screening invite, don't ignore it.' Dr Amanda Doyle, national director for primary care and community services at NHS England, said: 'The NHS HPV vaccination programme has already helped save thousands of lives and we need to go further to boost uptake of HPV vaccines and cervical screening to help eliminate cervical cancer in England by 2040. 'If we can ensure that almost every Year 10 girl in some areas is protected and extremely unlikely to ever develop cervical cancer, we need to match this in every part of the country.' Roughly two women in Britain every day die from cervical cancer, which famously killed TV personality Jade Goody at the age of just 27. The disease is often called a 'silent killer' because its symptoms can be easily mistaken for less serious problems, such as heavy periods and exhaustion. But if the signs are recognised early, the chance of surviving for at least five years is roughly 95 per cent. This drops to 15 per cent if the cancer is detected at later stages, when it has spread to other areas of the body. Children are offered the HPV jab in early adolescence because it is considered to be most effective if given before someone becomes sexually active. UKHSA highlighted the low rates of HPV vaccine uptake as part of Cervical Cancer Screening Awareness week. Currently women aged 25 to 49 in the UK are invited for a cervical screening check at their GP surgery every five years. They were previously offered screening every three years, but this was r ecently changed after the longer time period was found to be just as effective. For those aged between 50 and 64, it is offered every five years. Screening is arguably all the more important for women aged 34 and above, who did not receive a vaccine that protects against the vast majority of cervical cancers as part of the school programme introduced in 2008. Depending on the result of the smear test, some women may be recalled earlier than the three-year routine intervals. But screening uptake overall remains low. Only around 70 per cent of eligible women, roughly 4.6million, turn up for their scheduled test. Embarrassment is a factor, according to research by cervical cancer charities.
